Everolimus immunosuppression reduces the serum expression of fibrosis markers in liver transplant recipients

doi:10.5500/wjt.v4.i2.133

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 4, Issue 2

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5254)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-4) series.

Item

Count

PDF

311

WORD

344

HTML

2488

Figures (1-1)

234

Tables (1-4)

117

Sum=3494

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

845

Download

915

Sum=1760

Jun 24, 2014 (publication date) through Apr 28, 2024

Times Cited of This Article

Times Cited (17)

Journal Information of This Article

Publication Name

World Journal of Transplantation

ISSN

2220-3230

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Research Report

World J Transplant. Jun 24, 2014; 4(2): 133-140
Published online Jun 24, 2014. doi: 10.5500/wjt.v4.i2.133

Table 3 Serum levels of liver fibrosis mediators

	Everolimus patients(n = 30)	CNI patients(n = 30)	P value
VCAM (ng/mL)	68.25 (25.98-135.17)	58.88 (35.30-115.52)	0.668
PIIINP (ng/mL)	172.4 (119.75-1195.90)	879.40 (140.10-1555.15)	0.193
IP-10 (pg/mL)	86.01 (51.10-210.91)	79.61 (59.2-172.64)	0.669
HGF (pg/mL)	225.17 (163.30-320.17)	205.53 (152.59-297.86)	0.363
Angiopoietin (ng/mL)	26.97 (19.58-32.25)	30.108 (24.60-38.8)	0.122
TNF-α (ng/mL)	41.12 (38.35-44.8)	42.70 (40.20-45.07)	0.435
IL-10 (pg/mL)	8.52 (6.07-9.23)	8.66 (6.95-9.40)	0.856
TGF-β (ng/mL)	12.7 (3.7-133.6)	152.5 (14.4-333.2)	0.009
HA (ng/mL)	702.89 (329.4-838.2)	1513.6 (691.9-1951.4)	0.001
PDGF (ng/mL)	1.5630 (1.4663-1.6369)	1.5630 (1.4616-1.6369)	0.720

Variables are expressed as medians and interquartillic range. VCAM: Vascular cell adhesion molecule; PIIINP: Amino-terminal propeptide of type III procollagen; IP10: Interferon-inducible protein 10 calcineurin inhibitor; TNF-α: Transforming necrosis factor alpha; TGF: Tissue growth factor; HGF: Hepatocyte growth factor; HA: Hyaluronic acid; PDGF: Platelet derived growth factor.

Citation: Fernández-Yunquera A, Ripoll C, Bañares R, Puerto M, Rincón D, Yepes I, Catalina V, Salcedo M. Everolimus immunosuppression reduces the serum expression of fibrosis markers in liver transplant recipients. World J Transplant 2014; 4(2): 133-140
URL: https://www.wjgnet.com/2220-3230/full/v4/i2/133.htm
DOI: https://dx.doi.org/10.5500/wjt.v4.i2.133